Làm giảm KPNA2 thúc đẩy ferroptosis trong ung thư thanh quản bằng cách kích hoạt con đường tín hiệu FoxO

Carracedo DG et al (2008) Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications. Oncol Rep 20(3):589–595 Ciolofan MS et al (2017) Clinical, histological and immunohistochemical evaluation of Larynx Cancer. Curr Health Sci J 43(4):367–375 Cui X et al (2021) Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling. J Ovarian Res 14(1):71 Dilmac S et al (2022) SIRT1/FOXO signaling pathway in breast cancer progression and metastasis. Int J Mol Sci 23(18):10227 Ding K et al (2023) Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl) 136(21):2521–2537 Dong T et al (2017) FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition. Oncotarget 8(1):1703–1713 Du M et al (2022) MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma. Cell Death Discov 8(1):53 Fík Z et al (2013) Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas. J Oral Pathol Med 42(2):166–173 Fu D et al (2021) Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. Cell Mol Biol Lett 26(1):26 Gegotek A, Skrzydlewska E (2019) Biological effect of protein modifications by lipid peroxidation products. Chem Phys Lipids 221:46–52 Guo X et al (2019) Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types. Acta Biochim Biophys Sin (Shanghai) 51(3):285–292 Han Y, Wang X (2020) The emerging roles of KPNA2 in cancer. Life Sci 241:117140 Hong T et al (2021) PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol 42:101928 Hu Y et al (2021a) Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approaches. PLoS ONE 16(11):e0259436 Hu ZW et al (2021b) Ferroptosis driver SOCS1 and suppressor FTH1 independently correlate with M1 and M2 macrophage infiltration in Head and Neck squamous cell carcinoma. Front Cell Dev Biol 9:727762 Jeong D et al (2017) Karyopherin alpha-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer. J Cancer Res Clin Oncol 143(12):2493–2503 Jiang L et al (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520(7545):57–62 Jiang H, He Q, Liu T (2021) BBOX1-AS1 accelerates nasopharyngeal carcinoma progression by sponging mir-3940-3p and enhancing KPNA2 Upregulation. Cancer Manag Res 13:9049–9062 Jiang Z et al (2022a) A Ferroptosis-Related lncRNA Model to Enhance the Predicted Value of Cervical Cancer. J Oncol 2022:6080049 Jiang Y et al (2022b) Ferroptosis related genes in ischemic and idiopathic cardiomyopathy: screening for potential pharmacological targets. Front Cell Dev Biol 10:817819 Kang R, Kroemer G, Tang D (2019) The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med 133:162–168 Lang X et al (2019) Radiotherapy and Immunotherapy Promote Tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov 9(12):1673–1685 Lee J, Roh JL (2022) Induction of ferroptosis in head and neck cancer: a novel bridgehead for fighting cancer resilience. Cancer Lett 546:215854 Lei G et al (2020) The role of ferroptosis in ionizing radiation-induced cell death and tumo suppression. Cell Res 30(2):146–162 Li MM et al (2021) Stage Migration and Survival trends in Laryngeal Cancer. Ann Surg Oncol 28(12):7300–7309 Li D et al (2023) CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene 42(2):83–98 Lin F et al (2018) Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Oncol Rep 40(1):179–194 Liu J et al (2010) Suppression of S-phase kinase-associated protein 2 induces apoptosis and inhibits tumor growth in human laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 72(4):205–214 Ma A et al (2019) USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis. Oncogene 38(13):2405–2419 MacNeil SD (2023) Non-squamous laryngeal Cancer. Otolaryngol Clin North Am 56(2):345–359 Mou Y et al (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1):34 Niu H et al (2022) Effects of USP7 on radiation sensitivity through p53 pathway in laryngeal squamous cell carcinoma. Transl Oncol 22:101466 Nocini R et al (2020) Updates on larynx cancer epidemiology. Chin J Cancer Res 32(1):18–25 Peschos D et al (2005) Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. J Exp Clin Cancer Res 24(3):431–437 Roh JL et al (2017) Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol 11:254–262 Sardella A et al (2012) Morphological evaluation of tongue mucosa in burning mouth syndrome. Arch Oral Biol 57(1):94–101 Schwartz N et al (2019) Estradiol receptor profile and estrogen responsiveness in laryngeal cancer and clinical outcomes. Steroids 142:34–42 Shan Z et al (2019) CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer. J Cell Mol Med 23(5):3130–3139 Shin D et al (2018) Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med 129:454–462 Siegel RL et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48 Steuer CE et al (2017) An update on larynx cancer. CA Cancer J Clin 67(1):31–50 Verma A et al (2019) Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer. Steroids 152:108498 Wang CI et al (2016) mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells. Oncotarget 7(18):25432–25442 Wang CI et al (2018) Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer. Head Neck 40(8):1719–1733 Wang QD et al (2023a) USP21 contributes to the aggressiveness of laryngeal cancer cells by deubiquitinating and stabilizing AURKA. Kaohsiung J Med Sci 39(4):354–363 Wang CK et al (2023b) MEX3A mediates p53 degradation to suppress ferroptosis and facilitate ovarian Cancer tumorigenesis. Cancer Res 83(2):251–263 Wangzhou K et al (2023) microRNA-17 is a tumor suppressor in oral squamous cell carcinoma and is repressed by LSD1. Oral Dis 29(2):491–504 Xie L et al (2023) Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway. Phytomedicine 114:154748 Yang L et al (2016) Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer. Oncol Rep 36(2):819–826 Yang J et al (2019) DIAPH1 is upregulated and inhibits cell apoptosis through ATR/p53/Caspase-3 signaling pathway in laryngeal squamous cell carcinoma. Dis Markers 2019:p6716472 Yang C et al (2021) Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin. Aging 13(10):13515–13534 Yu L et al (2017) Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer. Oncol Lett 13(3):1194–1200 Zeng R (2016) Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 30(5):349–352 356 Zhang Y et al (2021) p53 promoted ferroptosis in ovarian Cancer cells treated with human serum incubated-superparamagnetic Iron oxides. Int J Nanomedicine 16:283–296 Zhang C et al (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21(1):47 Zhao L et al (2022) Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond) 42(2):88–116